Abstract:One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action. One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action.

PS 07-21 ASSOCIATION OF TWO SNPs rs2296545 AND rs2576178 IN RENALASE GENE WITH HYPERTENSION RISK: A META-ANALYSIS

Association of Renalase Snps Rs2296545 and Rs2576178 with the Risk of Hypertension: A Meta-Analysis

Association of Single Nucleotide Polymorphisms in ADIPOQ Gene with Risk of Hypertension: a Systematic Review and Meta-Analysis.

Association of A-20C polymorphism in the angiotensinogen gene with essential hypertension: a meta-analysis.

Association of AT1R polymorphism with hypertension risk: An update meta-analysis based on 28,952 subjects.

Comprehensive Assessment of the Association of WNK4 Polymorphisms with Hypertension: Evidence from a Meta-Analysis

A46G and C79G polymorphisms in the β2-adrenergic receptor gene ( ADRB2 ) and essential hypertension risk: a meta-analysis

A46G AND C79G POLYMORPHISMS IN BETA2-ADRENERGIC RECEPTOR GENE (ADRB2) AND ESSENTIAL HYPERTENSION RISK: A META-ANALYSIS: PP.21.327

Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals

The Contributory Role of Angiotensin Receptor-Like 1 Gene Multiple Polymorphisms in Hypertension among Northeastern Han Chinese

Review: Association Between Angiotensin Converting Enzyme G2350A Polymorphism and Hypertension Risk: a Meta-Analysis

Common Polymorphism Rs11191548 Near the Cyp17a1 Gene is Associated with Hypertension and Systolic Blood Pressure in the Han Chinese Population

Lack of Association Between Α-Adducin G460W Polymorphism and Hypertension: Evidence from a Case–control Study and a Meta-Analysis

Lack of association between |[alpha]|-adducin G460W polymorphism and hypertension: evidence from a case|[ndash]|control study and a meta-analysis

Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses

Haplotype-based association of regulator of G-protein signaling 5 gene polymorphisms with essential hypertension and metabolic parameters in Chinese.

Associations between polymorphisms of the CXCL12 and CNNM2 gene and hypertension risk: A case-control study

ASSA14-02-01 the Association of Polymorphisms in Renin-angiotensin-aldosterone System and Atrial Fibrillation in Chinese Han Population

AGT, CYP11B2 & ADRB2 gene polymorphism & essential hypertension (HT): A meta-analysis

Interleukin-6 Promoter −174G/C Polymorphism and Hypertension: A Case–control Study and a Meta-Analysis

Association Between ALDH-2 rs671 and Essential Hypertension Risk or Blood Pressure Levels: A Systematic Review and Meta-Analysis